SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-098528
Filing Date
2023-04-12
Accepted
2023-04-12 08:40:58
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d492459ddefa14a.htm DEFA14A 11335
2 GRAPHIC g492459g02a77.jpg GRAPHIC 404557
3 GRAPHIC g492459g03b88.jpg GRAPHIC 239715
  Complete submission text file 0001193125-23-098528.txt   896912
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39782 | Film No.: 23814715
SIC: 2836 Biological Products, (No Diagnostic Substances)